Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 06-04-2015 | Practice Area: | Equity Capital Markets |
| Deal Title: | Mylan NV Secondary NASDAQ Offering of Ordinary Shares | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Davis Polk advised Morgan Stanley and Co. LLC and Goldman, Sachs and Co. as joint book-running managers on Mylan N.V.'s USD2 billion SEC-registered secondary offering of 35,000,000 ordinary shares sold by certain subsidiaries of Abbott Laboratories. The ordinary shares are listed on the NASDAQ Global Select Market under the symbol MYL.
The Davis Polk capital markets team included partner Michael Kaplan and associates Ferrell Maguire, Skawenniio Barnes and Jennifer Wang.
|
||
| Financial Center: | New York | Value: | 1000.01-5000.00 |
| Advised Party: | Lead Manager | Law Firm | Davis Polk |
| Issuer Jurisdiction - | United States | Listing Jurisdiction - | United States |
| Classification: |
Secondary Offerings and Placings NASDAQ: |
Lawyer | Michael Kaplan |
